748 related articles for article (PubMed ID: 34296312)
1. Dimethyl itaconate inhibits LPS‑induced microglia inflammation and inflammasome‑mediated pyroptosis via inducing autophagy and regulating the Nrf‑2/HO‑1 signaling pathway.
Yang S; Zhang X; Zhang H; Lin X; Chen X; Zhang Y; Lin X; Huang L; Zhuge Q
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296312
[TBL] [Abstract][Full Text] [Related]
2. Oxymatrine attenuates oxidized low‑density lipoprotein‑induced HUVEC injury by inhibiting NLRP3 inflammasome‑mediated pyroptosis via the activation of the SIRT1/Nrf2 signaling pathway.
Jin X; Fu W; Zhou J; Shuai N; Yang Y; Wang B
Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368883
[TBL] [Abstract][Full Text] [Related]
3. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
[TBL] [Abstract][Full Text] [Related]
4. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
Front Immunol; 2019; 10():1511. PubMed ID: 31327964
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl itaconate protects against lippolysacchride-induced mastitis in mice by activating MAPKs and Nrf2 and inhibiting NF-κB signaling pathways.
Zhao C; Jiang P; He Z; Yuan X; Guo J; Li Y; Hu X; Cao Y; Fu Y; Zhang N
Microb Pathog; 2019 Aug; 133():103541. PubMed ID: 31100405
[TBL] [Abstract][Full Text] [Related]
6. Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway.
Huang C; Zhang C; Yang P; Chao R; Yue Z; Li C; Guo J; Li M
Drug Des Devel Ther; 2020; 14():4901-4913. PubMed ID: 33223823
[TBL] [Abstract][Full Text] [Related]
7. Melatonin alleviates lipopolysaccharide (LPS) / adenosine triphosphate (ATP)-induced pyroptosis in rat alveolar Type II cells (RLE-6TN) through nuclear factor erythroid 2-related factor 2 (Nrf2)-driven reactive oxygen species (ROS) downregulation.
Zhou T; Li Z; Chen H
Bioengineered; 2022 Jan; 13(1):1880-1892. PubMed ID: 35109747
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia/Macrophage Pyroptosis through NF-
Ran Y; Su W; Gao F; Ding Z; Yang S; Ye L; Chen X; Tian G; Xi J; Liu Z
Oxid Med Cell Longev; 2021; 2021():1552127. PubMed ID: 34630845
[TBL] [Abstract][Full Text] [Related]
9. Itaconate confers tolerance to late NLRP3 inflammasome activation.
Bambouskova M; Potuckova L; Paulenda T; Kerndl M; Mogilenko DA; Lizotte K; Swain A; Hayes S; Sheldon RD; Kim H; Kapadnis U; Ellis AE; Isaguirre C; Burdess S; Laha A; Amarasinghe GK; Chubukov V; Roddy TP; Diamond MS; Jones RG; Simons DM; Artyomov MN
Cell Rep; 2021 Mar; 34(10):108756. PubMed ID: 33691097
[TBL] [Abstract][Full Text] [Related]
10. Isoliquiritigenin alleviates P. gingivalis-LPS/ATP-induced pyroptosis by inhibiting NF-κB/ NLRP3/GSDMD signals in human gingival fibroblasts.
Lv X; Fan C; Jiang Z; Wang W; Qiu X; Ji Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108338. PubMed ID: 34794890
[TBL] [Abstract][Full Text] [Related]
11. Melatonin attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3-GSDMD pathway via activating Nrf2/HO-1 signaling axis.
Kang JY; Xu MM; Sun Y; Ding ZX; Wei YY; Zhang DW; Wang YG; Shen JL; Wu HM; Fei GH
Int Immunopharmacol; 2022 Aug; 109():108782. PubMed ID: 35468366
[TBL] [Abstract][Full Text] [Related]
12. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
Lei Q; Yi T; Chen C
Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl itaconate reprograms neurotoxic to neuroprotective primary astrocytes through the regulation of NLRP3 inflammasome and NRF2/HO-1 pathways.
Darvish Khadem M; Tabandeh MR; Haschemi A; Kheirollah A; Shahriari A
Mol Cell Neurosci; 2022 Sep; 122():103758. PubMed ID: 35868484
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1.
Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M
Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992
[TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.
Hu Q; Zhang T; Yi L; Zhou X; Mi M
Biofactors; 2018 Mar; 44(2):123-136. PubMed ID: 29193391
[TBL] [Abstract][Full Text] [Related]
16. Luteolin prevents THP-1 macrophage pyroptosis by suppressing ROS production via Nrf2 activation.
Zou Y; Luo X; Feng Y; Fang S; Tian J; Yu B; Li J
Chem Biol Interact; 2021 Aug; 345():109573. PubMed ID: 34217685
[TBL] [Abstract][Full Text] [Related]
17. Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway.
Shen J; Fan Z; Sun G; Qi G
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296299
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration.
Tufekci KU; Ercan I; Isci KB; Olcum M; Tastan B; Gonul CP; Genc K; Genc S
Immunol Lett; 2021 May; 233():20-30. PubMed ID: 33711331
[TBL] [Abstract][Full Text] [Related]
19. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling.
Lin Y; Luo T; Weng A; Huang X; Yao Y; Fu Z; Li Y; Liu A; Li X; Chen D; Pan H
Front Immunol; 2020; 11():580593. PubMed ID: 33365024
[TBL] [Abstract][Full Text] [Related]
20. Investigation on the mechanism of mafenide in inhibiting pyroptosis and the release of inflammatory factors.
Han C; Yang Y; Yu A; Guo L; Guan Q; Shen H; Jiao Q
Eur J Pharm Sci; 2020 Apr; 147():105303. PubMed ID: 32173407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
